Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

SIS3 (free base)

SIS3 free base is a potent and selective inhibitor of Smad3 phosphorylation. SIS3 free base inhibits the myofibroblast differentiation of fibroblasts by TGF-β1. SIS3 free base does not affect the phosphorylation of Smad2[1].

Product Specifications

CAS Number

[521985-36-4]

UNSPSC

12352005

Target

TGF-beta/Smad

Type

Reference compound

Related Pathways

Stem Cell/Wnt; TGF-beta/Smad

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/sis3-freebase.html

Concentration

10mM

Purity

98.02

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

O=C(/C=C/C1=C(N(C2=NC=CC=C21)C)C3=CC=CC=C3)N4CC5=C(CC4)C=C(C(OC)=C5)OC

Molecular Formula

C28H27N3O3

Molecular Weight

453.53

References & Citations

[1]Jinnin M, et al. Characterization of SIS3, a novel specific inhibitor of Smad3, and its effect on transforming growth factor-beta1-induced extracellular matrix expression. Mol Pharmacol. 2006 Feb;69 (2) :597-607. Epub 2005 Nov 15.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Citation 01

Antioxidants (Basel) . 2022 Dec 15;11 (12) :2469.|Cell Biol Int. 2023 Apr;47 (4) :754-767.|Cell Transplant. 2023 Jan-Dec:32:9636897231162526.|Cell Transplant. 2023 Jan-Dec:32:9636897231177356.|FASEB J. 2022 Dec;36 (12) :e22625.|J ImmunoTher Cancer. 2020 Aug;8 (2) :e000422. |J Transl Med. 2025 Jul 10;23 (1) :763.|Theranostics. 2021 May 13;11 (14) :7110-7125.|Acta Histochem. 2023 Feb;125 (2) :152010.|Am J Physiol Cell Physiol. 2022 Jul 1;323 (1) :C133-C144.|Am J Physiol Renal Physiol. 2023 May 1;324 (5) :F433-F445.|Am J Reprod Immunol. 2021 Mar;85 (3) :e13344.|Am J Transl Res. 2020 Feb 15;12 (2) :478-492.|Am J Transl Res. 2021 Sep 15;13 (9) :10908-10921.|Antioxidants (Basel) . 2022 Dec 15;11 (12) :2469.|Aquaculture. 15 September 2022, 738360.|Bioact Mater. 2025 Oct 15:56:77-94.|Biochem Pharmacol. 2022 Jan:195:114846.|Biochem Pharmacol. 2023 Oct:216:115796.|Biochim Biophys Acta Mol Basis Dis. 2018 Nov;1864 (11) :3824-3836.|Biochim Biophys Acta Mol Cell Res. 2022 May 13;1869 (9) :119285.|Biol Reprod. 2025 Aug 7:ioaf179.|Biomed Pharmacother. 2023 Mar:159:114216.|Biomed Pharmacother. 2023 Sep:165:115225.|Biomed Pharmacother. 2025 May 1:187:118094.|bioRxiv. 2025 Jun 24.|bioRxiv. 2025 May 05.|BMC Med. 2021 Oct 15;19 (1) :247.|Brain Behav Immun. 2021 Jul:95:154-167.|Brain Res. 2022 Jan 15:1775:147711.|Cancer Cell Int. 2024 Mar 25;24 (1) :114.|Cancer Cell. 2024 Apr 8;42 (4) :682-700.e12.|Cell Commun Signal. 2025 Nov 12;23 (1) :492.|Cell Commun Signal. 2025 Sep 30;23 (1) :402.|Cell Death Differ. 2021 Mar;28 (3) :1001-1012.|Cell Death Dis. 2024 Dec 24;15 (12) :930.|Cell Death Discov. 2021 Oct 4;7 (1) :273.|Cell Discov. 2025 Mar 11;11 (1) :22.|Cell Mol Life Sci. 2025 Aug 8;82 (1) :303.|Chin Herb Med. 2025 Jul 23.|Chin Med. 2022 Feb 21;17 (1) :25.|Clin Epigenetics. 2023 Nov 11;15 (1) :182.|CNS Neurosci Ther. 2022 Nov;28 (11) :1883-1894.|Commun Biol. 2025 Jul 29;8 (1) :1127.|Commun Biol. 2025 Mar 8;8 (1) :396.|Curr Med Sci. 2024 Jun;44 (3) :519-528.|Drug Dev Res. 2023 Dec;84 (8) :1751-1763.|Drug Dev Res. 2025 Nov;86 (7) :e70175.|EMBO Mol Med. 2024 Apr;16 (4) :870-884.|Eur Rev Med Pharmaco. 2021; 25 (2) : 787-794.|Fish Shellfish Immunol. 2020 Feb;97:455-464.|Front Biosci (Landmark Ed) . 2024 Sep 24;29 (9) :336.|Front Cell Dev Biol. 2020 Sep 18:8:858.|Front Pharmacol. 2018 Jun 21:9:660.|Front Pharmacol. 2021 Dec 16:12:774316.|Immunol Lett. 2019 Feb:206:33-40.|Int Immunopharmacol. 2024 Sep 18;142 (Pt B) :113186.|Int J Clin Exp Med. 2016;9 (8) :15892-15899.|Int J Mol Med. 2019 Feb;43 (2) :993-1002. |iScience. 2023 May 29;26 (7) :106994.|J Biol Chem. 2024 Feb;300 (2) :105605.|J Cell Biochem. 2019 Oct;120 (10) :17872-17886. |J Cell Mol Med. 2021 Dec;25 (24) :11113-11127.|J Cell Mol Med. 2024 Nov;28 (22) :e70214.|J Cell Mol Med. 2025 Mar;29 (5) :e70486.|J Cell Physiol. 2020 Jan;235 (1) :429-441.|J Cell Physiol. 2024 Mar;239 (3) :e31062.|J Clin Transl Hepatol. May 26, 2022.|J Dent Sci. 2023 Apr;18 (2) :865-871.|J Ethnopharmacol. 2023 May 10:307:116243.|J Invest Dermatol. 2019 Jan;139 (1) :224-234.|J Pers Med. 2022 Mar 2;12 (3) :385.|Life Sci. 2023 May 1:320:121540.|Life Sci. 2025 May 22:376:123755.|mBio. 2025 Jul 31:e0136625.|Med Sci Monit. 2018 Nov 18:24:8290-8297.|MedComm (2020) . 2025 Mar 27;6 (4) :e70148.|Meharry Medical College. 2024.|Mol Immunol. 2018 Nov:103:173-181.|Mol Med Rep. 2019 Aug;20 (2) :1605-1612.|Nat Commun. 2025 Oct 3;16 (1) :8826.|Neural Regen Res. 2024 Jan;19 (1) :180-189.|NPJ Regen Med. 2020 Oct 30;5 (1) :19.|Nucleic Acids Res. 2023 Apr 11;51 (6) :2655-2670.|Oncogenesis. 2021 Oct 27;10 (10) :72.|Parasit Vectors. 2020 Apr 3;13 (1) :164.|Phytother Res. 2023 Feb;37 (2) :717-730.|Redox Biol. 2023 Jun:62:102709.|Research Square Preprint. 2020 Nov.|Research Square Preprint. 2021 May.|Research Square Preprint. 2023 Jun 19.|Research Square Print. September 15th, 2022.|Sci Rep. 2017 Sep 8;7 (1) :11006. |Sci Rep. 2022 Feb 23;12 (1) :3053.|Stem Cell Res. 2020 Dec;49:102099.|Tissue Cell. 2025 Jul 29:97:103061.|Tissue Eng Regen Med. 2021 Dec;18 (6) :963-973.|Tissue Eng Regen Med. 2022 Jun;19 (3) :577-588.|Wright State University. 2023 Feb 23.

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Human FBXO9 siRNA
abx901920-01 15 nmol

Human FBXO9 siRNA

Ask
View Details
Human FBXO9 siRNA
abx901920-02 30 nmol

Human FBXO9 siRNA

Ask
View Details
Rabbit MUC1 (Mucin 1) ValidElisa Kit
EK346763 96 Well

Rabbit MUC1 (Mucin 1) ValidElisa Kit

Ask
View Details
Interleukin 21 Receptor (IL21R) Antibody
abx113248 100 µL

Interleukin 21 Receptor (IL21R) Antibody

Ask
View Details
Recombinant Alteromonas macleodii Probable rRNA maturation factor (MADE_1007145)
MBS1173448-01 0.02 mg (E-Coli)

Recombinant Alteromonas macleodii Probable rRNA maturation factor (MADE_1007145)

Ask
View Details
Recombinant Alteromonas macleodii Probable rRNA maturation factor (MADE_1007145)
MBS1173448-02 0.1 mg (E-Coli)

Recombinant Alteromonas macleodii Probable rRNA maturation factor (MADE_1007145)

Ask
View Details